ALS and MS Clinical Data from Clene's CNM-Au8® Featured

SALT LAKE CITY, April 25, 2023 (GLOBE NEWSWIRE) -- Clene Inc. (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) a...

Related Keywords

Harvard University , Massachusetts , United States , Utah , Maryland , Salt Lake City , Boston , Sydney , New South Wales , Australia , American , David Schull , Kevin Gardner , Michael Barnett , James Berry , Rob Etherington , Ignacio Guerrero Ros , Nasdaq , University Of Sydney , Access Program , American Academy Of Neurology , Twitter , Exchange Commission , Clene Inc , Linkedin , Russo Partners , Clene Nanomedicine Inc , Facebook , Clene Nanomedicine , Annual Meeting , Massachusetts General Hospital , Survival Benefit , Across Three Study Populations , Expanded Access , Private Securities Litigation Reform Act , Annual Report , 新浪香港 , 新浪 , 新浪網 , 香港 , Sina , Sina Com Hk , Hong Kong ,